Heart Attack Biomarkers and Heart Function Study
Part of Heart & circulation clinical trials.
This study looks at blood markers (inflammation and heart damage indicators) in patients who have just had a heart attack or severe chest pain. Researchers want to understand how these markers relate to heart function to improve patient care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with a heart attack or unstable angina (severe chest pain from blocked blood flow to the heart)
- Your symptoms started within the last 24 hours
- You do not have chronic inflammatory diseases, active infections, or cancer
- You do not have severe liver or kidney disease
- You have not been treated with clot-busting medications (thrombolysis) for this event
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood “biomarkers” (signals in blood tests) in people who arrive with symptoms that could be a heart attack. It may help doctors spot and manage acute heart problems sooner and more accurately.
This study examines blood samples from people with different types of coronary artery disease to understand the condition better. It may help doctors learn how to treat heart problems in the future.
This study is checking if a simple blood test (hs-CRP to albumin ratio) can help predict outcomes in people who have had a heart attack or unstable angina but are not getting an immediate balloon/stent procedure. It aims to use inflammation markers to guide better care.
This study collects information about symptoms and experiences during acute coronary syndromes, which are sudden, serious heart events like heart attacks or unstable angina. It may help researchers understand patterns of care and symptoms to improve future treatment and support.
This study is an international survey about acute coronary syndromes, which are sudden signs of heart-related problems. Your answers can help researchers better understand symptoms and care needs after these events.
This study tracks inflammation in patients who had a heart attack and received a stent. It aims to understand inflammation levels after the event.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.